Cellares is a biotechnology company that is developing a platform for automated cell engineering. The platform uses advanced robotics and machine learning algorithms to streamline the process of cell engineering, making it faster, more efficient, and more cost-effective. Cellares' technology has a wide range of potential applications, including the development of new cell therapies for cancer and other diseases. The company was founded in 2018 and is based in San Francisco, California.